|
BSE Code
|
Company
|
Date
|
Purpose
|
|
|
530697
|
Zenlabs Ethica
|
12-May-2025
|
Zenlabs Ethica Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 inter alia to consider and approve to consider and approve Audited Financial Results of the Company for the Quarter and Year ended 31st March 2025 and any other matter with the permission of the Chairman.
|
|
543985
|
Zaggle Prepaid
|
12-May-2025
|
Zaggle Prepaid Ocean Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 inter alia to consider and approve 1. To consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended on March 31 2025.
2. To consider allotment of equity shares to the eligible employees under Zaggle Employee Stock Option Scheme 2022 (Zaggle ESOP 2022 or Scheme)
|
|
512063
|
Wardwizard Healt
|
12-May-2025
|
Wardwizard Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 inter alia to consider and approve Pursuance to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended from time to time we here inform you that a meeting of the Board of Directors of Wardwizard Healthcare Limited (Formerly known as Ayoki Mercantile Limited) (the Company) is scheduled to be held on Monday May 12 2025 inter-alia to consider/approve the following matters:
(i) Appointment of Company Secretary and Compliance Officer of the Company.
(ii) Reconstitution of Committees of Board.
(iii) Any other matter with the permission of the Chair and majority of directors present in the meeting.
|
|
501370
|
Walchand People
|
12-May-2025
|
Walchand Peoplefirst Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 inter alia to consider and approve We wish to inform you that a meeting of the Board of Directors of Walchand PeopleFirst Limited (the Company) is scheduled to be held on Monday May 12 2025 inter alia to consider and approve the following agenda items:
1. To consider and approve the audited financial results of the Company for the quarter and financial year ended 31st March 2025.
2. Consider and recommend final dividend if any on the equity shares of the Company for the financial year ended 31st March 2025.
|
|
530057
|
Vivanza Biosci.
|
12-May-2025
|
Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 inter alia to consider and approve The Audited Standalone and Consolidated Financial statements and Financial results of the Company for the quarter and year ended March 31 2025 and 2. Any other business with the permission of Chair.
|
|
543298
|
Vineet Laborator
|
12-May-2025
|
Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 inter alia to consider and approve the Audited Standalone Financial Results of the Company for the Fourth Quarter and the Financial Year ended on March 31 2025.
|
|
543350
|
Vijaya Diagnost.
|
12-May-2025
|
Vijaya Diagnostic Centre Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 inter alia to consider and approve Audited Financial Results for the quarter and year ended March 31 2025
|
|
531717
|
Vidhi Specialty
|
12-May-2025
|
Vidhi Specialty Food Ingredients Ltd-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 inter alia to consider and approve financial results for the quarter and year ended March 31 2025 and recommendation of final dividend if any.
|
|
544321
|
Ventive Hospital
|
12-May-2025
|
Ventive Hospitality Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) the meeting of the Board of Directors of the Company is scheduled to be held on Monday May 12 2025 to inter-alia consider and approve the Audited Standalone and Consolidated financial results of the Company for the quarter and year ended March 31 2025.
|
|
523261
|
Venky's (India)
|
12-May-2025
|
Venkys (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 inter alia to consider and approve To Approve Audited Financial Results for the Quarter and Year ended 31st March 2025 and to consider recommendation of dividend on Equity Shares.
|